ABSTRACT
The functional investigation of redox cofactors is important for many potential biocatalytic processes, yet limited access to these molecules is often hampering efficient research activities. Deazaflavin‐dependent enzymes mediate a range of biochemical redox reactions in prokaryotes. Coenzyme F420‐dependent enzymes are interesting for asymmetric redox biocatalysis and other challenging reactions, but low F420 titers harvested from natural producers and engineered host strains so far limit intensive investigation of these enzymes. FO is a natural precursor of F420, which already shares many of the redox properties and was previously confirmed as a surrogate for F420 in certain enzymes. Here, we focused our research on the development of an overall process workflow from a 30‐L pilot scale stirred tank bioprocess to an optimized downstream purification process to obtain pure FO from an engineered Escherichia coli host strain. We were able to shift the cofactor synthesis from riboflavin to FO via the implementation of oxygen‐limited process conditions during heterologous fbiC expression and reached a final titer of 5.05 mg L−1 FO in our fermentation broth, which for the first time allows the purification of relevant amounts for subsequent experiments. Online fluorescence measurement within the bioreactor system made it possible to monitor FO formation and confirmed growth‐associated FO biosynthesis.
Keywords: deazaflavin purification, FO , F420 , Mycobacteria, process scale‐up, redox cofactor synthesis
Graphical Abstract and Lay Summary
This work studies the influence of oxygen availability on heterologous biosynthesis of the redox co‐factor FO with an engineered E. coli strain up to pilot scale. Microaerobic conditions led to a counter selection of the unwanted natural side product riboflavin and substantially increased titers of FO.

Abbreviations
- AC
adsorption chromatography
- AR
gas‐liquid surface (m2)
- CTR
carbon transfer rate (mmol L−1 h−1)
- DO
dissolved oxygen (%)
- DOT
dissolved oxygen tension (%)
- DR
reactor diameter (m)
- dstirrer
stirrer diameter (m)
- g
gravity constant (m s−1)
- Ne
power number, unaerated (‐)
- nstirrer
stirring rate (s−1)
- OTRmax,E
maximum OTR, derived from experiments (mmol L−1 h−1)
- OTRmax
maximum OTR, calculated (mmol L−1 h−1)
- OTR
oxygen transfer rate (mmol L−1 h−1)
- PR,30L,aerated
absolute power input 30‐L reactor, aerated (W)
- PR,7/30L,unaerated
absolute power input unaerated (W)
- PR,7L,aerated
absolute power input 7‐L reactor, aerated (W)
- qg
aeration rate (m3s−1)
- ug
gas velocity (m s−1)
- VG
gas flow volume (L h−1)
- VL
culture volume (L)
- V norm
ideal gas volume (L mol−1)
- VR
filling volume (m3)
- yC O2,in
concentration of carbon dioxide in gas in‐flow (‐)
- yC O2,out
concentration of carbon dioxide in off‐gas (‐)
- y O2,in
concentration of oxygen in gas in‐flow (‐)
- y O2,out
concentration of oxygen in off‐gas (‐)
1. Introduction
Oxidoreductases and their corresponding redox cofactors are important for many bioprocesses and chemical transformations. Unfortunately, when non‐standard cofactors like deazaflavins are involved, research on these cofactor‐dependent oxidoreductases is often hampered by the limited availability of the latter. Deazaflavin‐dependent enzymes gained more interest within recent years, as their distribution among bacteria and archaea was found to be more widespread than originally expected [1, 2, 3, 4]. F420 belongs to the group of deazaflavin cofactors, and its distribution has been attributed to archaea and bacteria species [5]. Several studies have evaluated the relevance of F420‐dependent enzyme families for biocatalysis [6, 7, 8, 9, 10, 11, 12] or predicted a great potential for biotechnological use. However, as the family of F420‐dependent enzymes is highly diverse and the structure and function of a wide range of these enzymes are not characterized yet, the topic of F420‐dependent enzymes is still underexplored [11]. In that regard, these articles also highlighted the need for the development of improved preparative production of cofactors and research directed into cofactor recycling [11, 13].
Coenzyme F420 itself is an inspirational redox cofactor that mediates a variety of hybrid transfer reactions [14] and contributes, for example, to antibiotic biosynthesis [15] or stress response in actinobacteria [16] and methanogenesis in archaea [17, 18]. However, investigation of F420‐dependent enzymes is restricted by the limited availability of the compound. The best natural producers only provide low quantities of F420 or are difficult to cultivate [19, 20]. A metabolically engineered strain of Mycobacterium smegmatis produced about 10 times higher amounts of the cofactor than the wildtype but is not ideally suited for bioprocess upscaling due to cultivation conditions and safety concerns [21]. The first heterologous productions of the cofactor in Escherichia coli were achieved by several groups [2, 19] and optimized in recent follow‐up studies [22, 23, 24].
In this work, our research interest is in the F420‐derivative FO. FO (7,8‐didemethyl‐8‐hydroxy‐5‐deazariboflavin) is a stable precursor during natural F420 biosynthesis and typically found in the culture supernatant of F420 producers [20, 23, 25, 26]. The precursor is mainly known as an antenna‐chromophore for DNA photolyases [27] that enhances the efficiency of DNA repair under low light conditions [28]. Interestingly, for some F420‐dependent enzymes, it was shown that FO can substitute for F420 in catalytic reactions [29, 30, 31]. On the contrary, some enzymes need the phosphorylated version, namely FOP [6], or even the fully mature cofactor for their activity [32, 33, 34, 35]. However, while investigating FOP synthesis and enzymatic utilization in Escherichia coli and Saccharomyces cerevisiae, FO substitution was necessary in Saccharomyces, as the strain was not able to perform the biosynthesis itself and could only further convert FO to its phosphorylated form [36, 37]. Further, members of our team could recently show that FO is involved in the maintenance of a bacterial‐fungal symbiosis, which hints towards a completely new role of FO in interspecies communication [38]. Overall, not many studies actively investigate the effect of the different variants of F420‐derivatives on the activity of the investigated enzymes or reactions. To enable a more thorough investigation of possible FO‐dependent reactions and processes, we here focused on the bioproduction of FO as our research goal.
The first synthetic chemistry approach for FO synthesis was reported in 2015 [29]. This protocol later was simplified and modified regarding the reductive amination procedure, combining two previous steps into one and thereby increasing the efficiency of the process [6]. In contrast, biological synthesis approaches, so far, were only achieved on small scales and with low overall yield [25, 39].
The responsible enzyme for FO biosynthesis, FO synthase, is either a two‐domain fusion protein in many bacteria, encoded by fbiC, [2, 40] or consists of two polypeptides, typically encoded by cofG and cofH in archaea [39, 41]. FO synthase utilizes 5‐amino‐6‐ribitylamino‐2,4(1H,3H)‐pyrimidinedion (ARP) and tyrosine as substrates for an oxidative coupling reaction [42]. The enzyme harbors two radical SAM domains and uses two separate 5’‐deoxyadenosyl radicals to catalyze FO formation [42]. ARP also represents a precursor of the riboflavin synthesis pathway [43, 44].
In this study, we installed and optimized the FO bioprocess in E. coli via microaerophilic process conditions to achieve higher product titers and established a sufficient downstream purification process that allows for further investigation of F420 substitution through FO in enzymatic reactions (Figure 1). During both the biosynthesis and the purification of FO, the processes had to be steered away from riboflavin as a ubiquitous cofactor. We performed a robust scale‐up of the process from shake flask into stainless steel bioreactors. The final working volume during this study was 20 L in 30‐L bioreactors.
FIGURE 1.

Biosynthesis of FO in E. coli pDB048 through the homologous two‐domain FbiC FO‐Synthase from Mycetohabitants rhizoxinica, which utilizes 5‐amino‐6‐ribitylamino‐2,4(1H,3H)‐pyrimidinedion (ARP) and tyrosine as substrates. The availability of oxygen greatly affects the ratio of FO and riboflavin (RF).
The two‐domain FO synthase (FbiC) from Mycetohabitans rhizoxinica [2] was expressed via an inducible plasmid system in the biotechnological host E. coli BL21 (Figure 1). We chose this enzyme for biosynthesis as it is derived from a Gram‐negative bacterium and might therefore perform more efficiently in E. coli than the well‐known archaeal or mycobacterial strains [36, 39].
Controlled oxygen conditions to steer carbon away from biomass formation and towards enhanced product formation were used in other studies to produce bulk chemicals and polymers in different host strains [45, 46, 47, 48]. Furthermore, a previous study showed that the availability of oxygen can be an important factor to enhance redox‐cofactor formation [49, 50]. The effect of high or low dissolved oxygen (DO) conditions on riboflavin synthesis and specifically, the upregulation of the Embden‐Meyerhof‐Pathway and the downregulation of the Pentose‐Phosphate‐Pathway under low DO conditions was extensively investigated in the common riboflavin production host Bacillus subtilis [51]. Another study examined the genetic effects of nitrogen metabolism and DO limitation on the regulation of riboflavin synthesis in B. subtilis [52]. However, this has not yet been evaluated for the biosynthesis of FO.
In this study, microaerobic conditions during the production phase favored FO over riboflavin and resulted in final product titers of 13.91 µmol L−1 (5.05 mg L−1), which is the highest reported titer for non‐natural FO producers, so far. Finally, a three‐stage purification process allowed for the fractionation of FO from the remaining riboflavin and ultimately yielded a pure product.
2. Material and Methods
2.1. Microbial Strain Construction and Cultivation Conditions
In this study, an E. coli BL21 strain, transformed with the pDB048 plasmid, was used for FO production. The plasmid pDB048 was obtained by insertion of the coding sequence of FO‐Synthase (fbiC) from M. rhizoxinica HKI‐454 [2] into vector pMGE‐T7 [53] at the EcoRV site. Gene expression is controlled by a T7 promotor with a lac operator. A kanamycin resistance cassette (KanR) serves as the selection marker.
Strain reactivation from cryo stocks was carried out in 30 mL Luria Broth medium (5 g L−1 yeast extract, 10 g L−1 peptone, 5 g L−1 NaCl). All experiments were conducted in liquid M9 medium (16 g L−1 Na2HPO4 x 12 H2O, 0.5 g L−1 NaCl, 3 g L−1 KH2PO4, 1 g L−1 NH4Cl, 10 mL L−1 Fe‐citrate solution (6 g L−1), 2 mL Zn(CH3COO)2 x 2 H2O solution (4 g L−1) and each 0.1 mL L−1 of EDTA (84 g L−1), CoCl2 x 6 H2O (25 g L−1), MnCl2 x 4 H2O (150 g L−1), CuCl2 x 2 H2O (15 g L−1), H3BO3 (30 g L−1), Na2MoO4 x 2 H2O (25 g L−1) solutions). Glycerol as carbon source (10 or 30 g L−1 for shake flask cultivation or stirred tank reactors, respectively), MgSO4 x 7 H2O (0.24 g L−1) and kanamycin (30 mg L−1) were added after autoclaving.
2.2. Pre‐culture
Prior to growth experiments or stirred tank reactor cultivations, a two‐step pre‐cultivation was performed. First, 100 µL of cryo stock was reactivated in 30 mL of LB (10% flask volume) at 37°C and 200 rpm shaking in an orbital shaker with a diameter of 70 mm. The second pre‐culture was inoculated to an OD of 0.01 in M9 media and grown at 37°C overnight. The size of the flask and the shaking frequency depended on the purpose of the following experiment.
2.3. Online Respiration Measurement in Shake Flask Cultivation
To enable online off‐gas measurements and calculation of the oxygen transfer rate (OTR) and carbon transfer rate (CTR) during shake flask cultivation, the TOM system from Kühner AG (Birsfelden, Switzerland) was used. To investigate four different levels of oxygen limitation 250 mL non‐baffled Erlenmeyer flasks (Kühner AG, Birsfelden, Switzerland) were filled with 10, 20, 30, and 40 mL of M9 medium in quadruplicate each and incubated at 37°C and 100 rpm (orbital shaking, 50 mm diameter). Every flask was equipped with an online monitoring system for oxygen and carbon dioxide off‐gas measurements. Supplied compressed air contained 0.04% (v/v) CO2 and 20.95% (v/v) O2. OTR (Equation 1) and CTR (Equation 2) were calculated according to the following equations [54]. Maximum theoretical OTRs were calculated to be 19.9, 11.9, 8.8, and 7.1 mmol L−1 h−1, respectively.
The inoculum was pre‐grown overnight, and flasks were inoculated to an OD600 of 0.1. Cultures were induced with 0.1 mM IPTG once the OTR reached one‐third of the calculated maxima. This online approach avoided interruptions of the cultivations for OD measurements to determine the time point for induction. Samples for HPLC were taken after 24 h of cultivation.
| (1) |
| (2) |
2.4. Cultivations in Stirred Tank Reactors
The first scale‐up step after shake flask cultivation was conducted in 7‐L glass reactors (BIOSTAT B‐DCU II, Sartorius Stedim Biotech, Göttingen, Germany) with a working volume of 4 L and controlled via the MFCS‐win software system (Sartorius, Göttingen, Germany). Off‐gas measurement was recorded via BlueSens Blue Vary gas sensors (BlueSens gas sensor GmbH, Herten, Germany). Ammonia (12.5%), sulfuric acid (10%), and antifoam reagent 204 (Merck KGaA, Darmstadt, Germany) were connected externally for pH regulation at 7 ± 0.05 and for foam control during the bioprocess. Two reactors were run in parallel, whereas one had a fixed stirring rate of 469 rpm to limit the oxygen supply and the other had a flexible stirring rate, starting at 300 rpm, that was controlled by the dissolved oxygen tension (DOT) sensor feedback. The DOT regulation was set to 20% to avoid any oxygen limitation during this fermentation run. Glycerol as a carbon source was prepared for a final concentration of 10 g L−1 and inoculation was done with a pre‐culture grown overnight in M9 medium. Product formation was induced with 0.1 mM IPTG after 5.5 h of cultivation. The process was stopped once complete glycerol consumption was confirmed.
The final production of FO was performed in a 30‐L stainless steel reactor with in‐situ sterilization (BIOSTAT_D‐DCU Twin MO 20L, Sartorius Stedim Biotech, Göttingen, Germany). The MFCS‐win software system (Sartorius, Göttingen, Germany) was used as a digital control system and for online recording. Off‐gas measurement was recorded with an external Emerson off‐gas‐analysis box (Rosemount NGA 2000, Emerson Process Management GmbH & Co, OHG, Haan, Germany). A tailor‐made fluorescence probe from C‐Technologies (C Technologies, Inc., Bridgewater, USA) was integrated directly into the bioreactor via a Schott Viewport (Schott AG, Mainz, Germany) and connected to an Agilent Cary Eclipse Fluorescence Spectrometer (Agilent Technologies, Santa Clara, USA). Sulfuric acid (12.5%), ammonia (25%), and antifoam reagent 204 (Merck KGaA, Darmstadt, Germany) were connected externally to ensure stable pH control at 7 ± 0.05 and to avoid excessive foaming during the process. As scale‐up criteria, the volumetric power input was chosen accordingly to the following equations (3), (4), (5), (6) [50, 55], and stirring was kept constant at 316 rpm (3‐step Rushton impeller) for limited oxygen supply.
| (3) |
| (4) |
| (5) |
| (6) |
The substrate glycerol was prepared for a final concentration of 30 g L−1. Inoculation was done with a pre‐culture grown overnight in M9. Product formation was induced with 0.1 mM IPTG once the DOT decreased to 20%. After 24 h, a second batch of 600 g glycerol was added to the bioreactor. The production process was stopped once DOT and HPLC results confirmed the complete depletion of glycerol.
2.5. Downstream Process
The downstream process employed two medium‐pressure liquid chromatography (MPLC) steps using an adsorption resin AmberChrom CG 161 M (DuPont, Wilmington, USA) with different pH, followed by one preparative HPLC step on a C18 reverse phase column with intermediary rotary evaporation and re‐dilution of defined fractions. In detail, the culture broth was first centrifuged, the supernatant filtered with Celpure P1000 (Advanced Minerals, Sheffield, UK) and adjusted to a pH of 3 for the first chromatography step. The acidified supernatant was loaded onto a 1L Amberchrom Column. The process was operated on an ÄKTApilot (Amersham Biosciences, Sweden), controlled by UNICORN software, and elution was monitored at 280, 395, 420 nm wavelengths. Increasing concentrations of methanol (0%, 10%, 50%, and 100%) were used as eluent. The 395 nm peak within the 50% MeOH fraction was collected and concentrated via rotary evaporation (Heidolph Instruments GmbH and Co. KG, Schwabach, Germany). The remaining solid was re‐diluted in bi‐distilled water, and the obtained solution was adjusted to a pH of 8. The intermediary purification proceeded on a 50 mL AmberChrom Column, on an ÄKTAexplorer (Pharmacia Biotech, Uppsala, Sweden), controlled via UNICORN software at 280, 395, and 420 nm. The product was monitored at 395 mm, eluted within the water and the 10% MeOH fraction, and was processed as before. A highly concentrated product solution was injected into a preparative HPLC set‐up (JASCO MD‐2015 plus Multiwavelength Detector and AS‐2050 plus Intelligent Sampler, Jasco International Co, Tokyo, Japan) equipped with a Eurospher II 100–10 C18 column (32 mm ×240 mm, Knauer, Berlin, Germany) and eluted with a gradient of 0.1% formic acid (eluent A) and acetonitrile (eluent B) in 20 min at a flow rate of 20 mL min−1. The collected product fraction was concentrated as described before, lyophilized (Alpha 1–4 LDC‐1m, Christ Gefriertrocknungsanlagen GmbH, Osterode, Germany), and stored at 4°C for further purity analysis or until further usage.
2.6. NMR Measurement
Lyophilized FO powder was dissolved in DMSO‐d6 (Merck KGaA, Darmstadt, Germany, 10 mg L−1), and 1H standard spectrum was measured in an Avance III 500 MHz Spectrometer (Bruker Massachusetts, USA) at 500 MHz. Analysis was conducted with TopSpin (Bruker, Massachusetts, USA).
2.7. Analytics
Glycerol and metabolites were analyzed via HPLC (X‐LC, Jasco International Co, Tokyo, Japan) with an Aminex HPX‐87H Ion Exclusion main‐column (300 mm × 7.8 mm, 9 µm, Bio‐Rad, Hercules CA, USA). Five millimolar H2SO4, with a flow of 0.5 mL min−1, was used isocratically as the mobile phase. Peak detection was performed by refractive index and UV (210 nm). Besides fluorescence measurement, FO formation was additionally quantified offline via UHPLC (Vanquish, Thermo Fisher Scientific, Waltham MA, USA), equipped with a Luna Omega PS C18 column (150 mm × 2.1 mm, 3 µm, Phenomenex, Torrance CA, USA). The mobile phase consisted of eluent A 0.1% formic acid in water and eluent B 0.1% formic acid in acetonitrile, with a flow of 0.15 mL min−1 and mixed in a gradient from 15% B to 100% B in 15 min and then back to 15% B in 16 min. Peak detection was monitored via fluorescence detector (ex 390 nm, em 470 nm) and DAD (395 nm).
3. Results and Discussion
A main challenge for efficient FO production is the competing formation of riboflavin through the interconnection of the biosynthetic pathways. We approached this challenge on both the upstream and downstream levels.
3.1. Oxygen Limitation Shifts Production From Riboflavin to FO
To investigate the effect of different levels of oxygen supply on FO‐formation by E. coli pDB048, four standard 250 mL Erlenmeyer flasks for the TOM respiration monitoring device were filled with 10, 20, 30, and 40 mL of culture media and used for parallel cultivation (Figure 2A). Thereby, the different filling volumes allowed to define theoretical maximum OTRs (OTRmax) for the different cultivations (20, 12, 9, and 7 mmol L−1 h−1, respectively). Off‐gas composition was measured online and the actual OTR (OTRE) and CTR were calculated (Figure 2B). FO biosynthesis was induced when approximately two‐thirds of the theoretical OTRmax was reached in each culture setup, respectively. After 24 h of cultivation, titers for riboflavin and FO were determined (Figure 2C). As previously noticed for other strains, a shift in redox cofactor formation was observed. Riboflavin formation drastically decreased from approximately 0.7 ± 0.04 mg L−1 (OTRmax,E 20 mmol L−1 h−1) to 0.05 ± 0.01 mg L−1 (OTRmax,E 5 mmol L−1 h−1) from cultures without oxygen limitation to conditions with lower OTR. On the other hand, FO production increased (Figure 2C). No distinct difference in the FO titer was observed between the 20, 30, and 40 mL cultures. These results might be due to the intrinsic oxygen sensitivity of the FO synthase [42] and thus microaerobic conditions might promote deazaflavin formation. However, the product titer for FO was still below 0.5 mg L−1 (0.4 ± 0.01 mg L−1, 1.1 ± 0.03 µmol L−1). Thus, the fraction of carbon source (glycerol) directed into FO biosynthesis was low under these conditions. For the active production phase of the culture (from induction to exhaustion of the substrate as indicated from the OTR signal), productivities of approximately 178, 136, 121, and 82 nmol L−1 h−1 (from high to low oxygen availability) were reached in the different cultures.
FIGURE 2.

Evaluation of different oxygen availabilities on FO and riboflavin biosynthesis by E. coli pDB048. Cells were grown in different volumes of M9 medium with glycerol as carbon source in shake flasks as quadruplicates. Uniform cultivation conditions were: 37°C, 100 rpm, 50 mm shaking diameter, 250 mL flasks, in a shaker equipped with the TOM off‐gas monitoring setup. Off‐gas O2 and CO2 values were measured and the OTR was calculated (B). The measured OTRmax,E and the corresponding filling volume are shown in (A). Titers of riboflavin (RF) and FO were measured via UHPLC after 24 h at the end of the cultivation (C).
A recent study investigated the effect of different E. coli host strains, FO synthase enzymes (FbiC from M. smegmatis and Streptomyces coelicolor and CofG/H from Methanocaldococcus jannaschii and Nostoc punctiforme) and media composition on FOP (the phosphorylated form of FO) formation in shake flask [36]. The authors demonstrated that high FO synthesis was crucial for further phosphorylation efficiency in FOP and concluded that increased fbic expression resulted in higher FOP production. Interestingly, the exchange of glucose with glycerol in M9 medium enhanced the FOP titer. However, cultivation on terrific broth yielded FOP titers that were more than 50 times higher (1.24 µmol L−1 in TB and 4.8 nmol L−1 in M9). Another study from 2021 reported that F420 biosynthesis in E. coli was heavily influenced by the choice of carbon source [24]. Positive influences on FOP and F420 production cannot be directly translated to FO production, since in those studies excessive FO production is usually avoided to prevent intermediate loss into the supernatant [23]. However, FO production and production of its derivatives, F420 and FOP, may still be affected by similar mechanisms. In our study, the highest titer of FO in shake flask with glycerol as a carbon source (1100 nmol L−1, average productivity 136 nmol L−1 h−1) was considerably higher than the titer published by Graham and colleagues (160 nmol L−1, in M9 with glucose). On the other hand, the highest average productivity for our work was found in a culture with no oxygen limitation (OTRmax,E of 20 mmol L−1 h−1, productivity 178 mmol L−1 h−1). However, since FO formation was not followed online, the overall productivities do not allow to judge on effective maximum productivities for the different oxygenation levels. We decided against the use of a complex medium, as we desired defined conditions within our process, especially in foresight of a targeted media optimization for higher cell densities in the future. Furthermore, certain compounds hinder or prolong the downstream processing of the fermentation broth. Our goal always included an efficient scale‐up and downstream design, and therefore the complexity of the whole process was to be kept concise. The target adjustment here was focused on the oxygen limitation, which was not investigated before and has been proven to have a great effect on the productivity within the chosen media conditions. However, further investigation into media optimization would be a worthwhile extension of our studies.
For example, as tyrosine is one of the two precursor molecules during FO formation, enhanced supply could lead to higher flux directed into the condensation reaction. But different studies presented contradictory results regarding this. In one study, a positive effect on final FO titers was confirmed for tyrosine supplementation (from 160 nmol L−1 to 640 nmol L−1, [39]). Though, in another study, the same approach did not result in a similar outcome [36].
In 2002, Isabelle and colleagues published a comparative study evaluating FO and F420 titers within cells and in cell supernatant in shake flask produced by various wildtype microbial strains [20]. Two different media that were rich in nutrients were used, depending on the host strain's preferences. The highest levels of FO in culture supernatants were 2.6 µmol L−1 (Streptomyces flocculus), 1.24 µmol L−1 (M. smegmatis) and 1.75 µmol L−1 (Rhodococcus opacus Rb1). Noteworthy, these strains may not be pathogenic, but in comparison to E. coli, current tools for metabolic engineering are more time‐consuming or limited, cell growth and maximum cell densities are lower, and scale‐up may be difficult.
3.2. Scale‐Up Into a 30‐L Stirred Tank Reactor
After evaluating the influence of the oxygen supply on the riboflavin and FO synthesis, a scale‐up strategy was designed based on the OTR as scale‐up criterion. Microaerophilic conditions are especially convenient for upscaling processes, as oxygen supply is usually one of the key limiting factors. A first scale‐up was conducted to two parallel 7‐L stirred tank reactors with a working volume of 4 L to confirm a positive effect of oxygen limitation through the application of a fixed stirring rate, which limits the OTRmax to approximately 20 mmol L−1 h−1 in comparison to an unlimited dissolved oxygen regulation to DOT = 20% through a variable stirring rate (OTRmax ∼ 70 mmol L−1 h−1) (Figure 3A,B). This strategy was chosen with the motivation to reach higher overall cell densities in combination with the induction of FO formation only a few minutes before reaching oxygen limitation.
FIGURE 3.

FO Fermentation with E. coli pDB048 under oxygen limited (R1, green) or unlimited (R2, blue) conditions in 7‐L glass bioreactors. Non‐limiting conditions were implemented through a DOT regulation at 20%, whereas oxygen limited conditions were reached through a fixed stirring rate (A). OD600 was measured offline and OTR and was calculated from online off‐gas measurements (A). FO and riboflavin titers were measured via UHPLC and shown are the final titers of the bioprocess (B). The FO yield was calculated for the total amount of product and the ODmax for both reactors respectively (D). Induction of FO formation through IPTG addition is marked with the dashed orange line.
These preliminary bioprocesses confirmed slightly enhanced FO titers and a strong reduction of riboflavin production without DOT regulation (Figures 3C and S1). Noteworthy, the oxygen limitation also resulted in a 4‐fold higher biomass related yield of FO (Figure 3D). In a subsequent 7‐L fermentation under equivalent oxygen limitation, we prolonged the FO production over the course of 24 h with higher initial glycerol concentrations leading to a 6‐fold increase in final FO titers compared to the initial 7‐L bioreactor (from 0.3 to 1.8 mg L−1, Figure S2).
Finally, the FO biosynthesis was scaled up to a 30‐L stainless steel bioreactor with a working volume of 20 L. Oxygen‐limited conditions were implemented by setting a fixed stirring rate of 316 rpm and a constant airflow of 5 L min−1 to reach an OTRmax,E of 10 mmol L−1 h−1 (Figure 4, independent repetition is shown in Figure S4). The higher oxygen limitation was chosen to further reduce riboflavin titers, while FO titers remained fairly stable during the experiments with limited and unlimited DOT conditions in the 7‐L bioreactor. During the previous flask experiment, the culture with an OTRmax of 10 mmol L−1 h−1 showed the highest productivity. This time, FO synthesis was induced 9.6 h after inoculation when approximately two‐thirds of the maximum OTR for these conditions was reached, and production was followed online by an inserted fluorescence probe (Figure 4A). Shortly after induction, oxygen limitation was reached, indicated by a DOT of zero. The initial glycerol was depleted after 24 h, and fresh glycerol was added to extend the fermentation process to 48 h (Figure 4B). The maximum glycerol consumption rates for both batches were approximately 1.8 g L−1 h−1. However, during the second feeding period, the measured online fluorescence (Figure 4C) indicated that no further product was biosynthesized after approximately 33 h. The remaining carbon source was utilized for neither FO nor biomass production, indicating the presence of a second substrate limitation for growth. However, as remaining glycerol was conflicting with the following downstream purification process, it was of utmost importance that all glycerol be consumed prior to the continuation of the process.
FIGURE 4.

FO production with E. coli pDB048 under oxygen‐limited conditions and with glycerol as carbon source in a stainless‐steel reactor (A). Dissolved oxygen tension within the fermentation broth was measured (DOT, green). Oxygen Transfer Rate (OTR, blue) was calculated from external online off‐gas measurements. OD600 (purple) was measured offline (B). Glycerol depletion (Gly, black), and product formation (FO, green triangles) were measured offline. For additional metabolite concentrations see Figure S3. Additionally, online FO monitoring was carried out via fluorescence measurements at 400 nm excitation and 466 nm emission (green line) (C). Induction of FO formation through IPTG addition is marked with the dotted orange line. An independent repetition is given in Figure S4.
Interestingly, of the four analyzed organic compounds acetic acid, succinic acid, lactic acid, and ethanol, only the lactic acid production changed after 33 h (Figure S3). At oxygen limitation, the CTR and the OTR were stable (Figure 4B), only to be interrupted by the effect of anti‐foam dosing into the reactor. Both rates reached maximum values (7 and 11 mmol L−1 h−1, respectively) when the oxygen limitation was reached, decreased shortly after, and remained at the lower level (5.5 and 9 mmol L−1 h−1, respectively) throughout the remaining process.
The final FO titer within this process was 13.91 µmol L−1 (5.05 mg L−1) in approximately 20 L of fermentation broth. The side product riboflavin only reached concentrations of 1.86 µmol L−1. With regards to the online fluorescence data, it can be concluded that FO synthesis correlates with cell growth, and this is equivalent to an average productivity of 548 nmol L−1 h−1 if a timeframe from 9.6 h (induction) up to 35 h (cease of production and end of active phase) is considered. Isabelle and colleagues proceeded their investigation of wildtype FO and F420 producers and transferred selected microbial strains into bioreactors as well [20]. Here, the highest FO titers were found in the supernatant of the M. smegmatis fermentation processes (6 µmol L−1). The whole process lasted 70 to 90 h, but only low productivity FO was found for the first 50 h. While the active phase of the bioprocess had a productivity of around 300 nmol L−1 h−1 (if we consider an FO biosynthesis for 20 h), the extensive production lag phase of 50 h would prevent a biotechnological exploitation. In another work, Kern et al. described the early appearance of a greenish compound during the Methanobacterium thermoautotrophicum fermentation process, which was later confirmed to be FO [25]. Approximately 25 mg FO was harvested from the 12 L fermentation (5.73 µmol L−1), however not many process parameters are reported.
For better comparison, all previously discussed data from both shake flask and bioreactor experiments are summarized in Table 1. This comparison highlights that our optimized bioprocess design with an engineered E. coli for heterologous FO production can compete with previous work and considerably surpasses the studies utilizing natural producers in a bioreactor setup. Noteworthy, we achieved our results without extensive media optimization, but with a focus on oxygen availability as a critical factor influencing the bioproduction. However, since our online fluorescence monitoring suggests a direct correlation of FO synthesis with growth, an extension of the growth phase could potentially lead to an extension of the FO production phase. Certainly, the fine‐tuning of effects of oxygen on the FbiC enzyme and the redox‐active product needs to be investigated in more detail.
TABLE 1.
Comparative summary of different studies on FO synthesis.
| Strain | Variant | Medium |
Product titer (mg L−1) |
Product titer (nmol L−1) |
Productivity (nmol L−1 h−1) |
Study |
|---|---|---|---|---|---|---|
| Shake flask | ||||||
| E. coli | FbiC | M9 (glycerol) | 0.40 | 1100 ± 30 | 136 | This study |
| E. coli | FbiC | M9 (glucose) | 0.06 | 160 | 80 | Graham et al. [39] |
| M9 (glucose) + tyrosine | 0.23 | 640 | 320 | Graham et al. [39] | ||
| LB | 0.11 | 290 | 145 | Graham et al. [39] | ||
| S. flocculus | Wt | MRS 1 | 0.94 | 2580 | n.d. | Isabelle et al. [20] |
| M. smegmatis | Wt | MRS 1 | 0.45 | 1240 | n.d. | Isabelle et al. [20] |
| R. opacus Rb1 | Wt | MRS 1 | 0.64 | 1750 | n.d. | Isabelle et al. [20] |
| Bioreactor | ||||||
| E. coli | FbiC | M9 (glycerol) | 5.05 | 13,900 | 548 | This study |
| M. thermo‐autotrophicum | Wt | A1 2 | 2.08 | 5740 | n.d. | Kern et al. [25] |
| M. smegmatis | Wt | MRS 1 | 2.18 | 6000 | 150–300 | Isabelle et al. [20] |
Note: The productivity was calculated from given process parameters if not stated directly in the results. Not defined (n.d.) parameters were not accessible through the given information within the published study.
MRS medium: 40 g L−1 glucose, 15 g L−1 yeast extract, 15 g L−1 soy peptone, 1.75 g L−1 NaH2PO4 x 4 H2O, 0.04 g L−1 ferric ammonium citrate, adjusted to pH 7.
A1 medium: A1 medium published by Andrews and Presnell [56]: 5 g L−1 lactose, 20 g L−1 tryptone, 5 g L−1 NaCl2, 0.5 g L−1 salicin, 1 mL L−1 Triton X‐100 but supplemented with 2.4 mg L−1 NiCl2 x 6 H2O.
3.3. Downstream Processing: Obtaining Pure FO
Concomitantly with optimizing the FO bioprocess, we designed an efficient downstream purification protocol to obtain the pure compound for further usage. The final downstream process for FO purification consists of three chromatography steps, intermitted by rotary evaporation for fraction concentration and preparation for the corresponding next chromatography step (Figure 5). During this process, separation of FO from structurally very similar metabolites like riboflavin was prioritized.
FIGURE 5.

Overview of the different downstream processing steps required for FO product purification from crude fermentation broth to the collection of a pure product. Schematic figures represent the station of the downstream process adsorption chromatography (AC) and preparative HPLC (pHPLC), intermitted by centrifugation (arrow), rotary evaporation (small round flask), and lyophilization (small falcon tube, A). The Sankey diagram below represents the fractions of riboflavin (RF, orange) and FO (green). The amount of RF and FO, labeled in the graph are representative for one bioprocess and the corresponding downstream process. Riboflavin is separated from FO after the intermediate purification at pH 8.
As described in 1983 by Kern et al., FO is membrane permeable and can be harvested from the crude cell broth without cell lysis [25]. This is beneficial for online product monitoring and simplifies the first step of the downstream process. The biomass can be discarded after separation, which was achieved via centrifugation. Centrifuged and filtered fermentation supernatant was adjusted to pH 3 and loaded onto a 1‐L chromatography column filled with AmberChrom CG 161 M resin. Elution was conducted with increasing concentrations of MeOH in bi‐distilled water, and FO was captured within the second peak fraction in 50% MeOH (Figure S5). Riboflavin, the main side product of FO biosynthesis, shares an overall similar molecular structure but distinct differences: N‐5 is replaced against a carbon atom, C‐7 and C‐8 are demethylated, and C‐7 is hydroxylated in FO [57, 58, 59]. At pH 3, the polarity of both compounds is similar, and therefore, both eluted in the second 50% MeOH fraction (Figure S5). However, other fermentation products and metabolites were successfully separated. To separate riboflavin and FO, another chromatography step was introduced subsequently. After the removal of MeOH residues in a rotational evaporator, the collected residue was suspended in bi‐distilled water and the pH was set to 8 prior to a second adsorption chromatography step. At pH 8, the structural differences yield different physiochemical properties for riboflavin and FO. The 8‐hydroxy group of FO deprotonates, leading to the formation of a delocalized phenolate above pH 6, induces increased chromatographic discrimination of both analytes on the apolar column material (Figure S6), whereby the majority of FO elutes before riboflavin. Eventually, the collected material was purified via preparative HPLC on a C18‐column. After lyophilization, the purity of the product was confirmed via 1H NMR measurement. The 500 MHz 1H NMR spectrum (3.46; 3.6; 3.66/3.64; 4.24; 4.49; 4.65; 4.67; 4.79; 4.96/4.95; 5.13/5.12; 7.04/7.02; 7.39; 8.01/8.03; 8.88; 10.97; 11.25 ppm, Figure S7) was in accordance with the results published previously [29].
A schematic view of the full downstream process is shown in Figure 5. In the presented example data, the concentration of FO within the fermentation broth was determined to be approximately 4 mg L−1 FO. About 53% of the product was harvested as pure FO. Product loss during purification can be attributed to different reasons: 27% of loss is attributed to the biomass separation, during which no washing was included, and potential degradation during preparation for the chromatography procedure. More product loss is attributed to the lengthy purification process and FO elution within non‐collected fractions (Figures S5 and S6).
A previously published FO purification comprised a total of four chromatography steps, including an adsorption chromatography via an Amberlite XAD‐4 column, subsequent anion exchange chromatography via a sephadex QAE A‐25 column, another adsorption chromatography via the previously used column setup and a final step via preparative HPLC on a Lichrosorb RP 18/10 µm column [25]. Our process requires one step less during intermediate purification, thus potentially minimizing the loss of product during the workup. Moreover, our process enabled the confirmed separation of contaminating compounds like riboflavin from the target compound.
4. Conclusion
In this study, we established a robust bioprocess for FO production with E. coli and performed a successful scale‐up to pilot scale to obtain preparative amounts of FO. We evolved the bioprocess from shake flask, over 7‐L glass to 30‐L stainless steel pilot bioreactors with controlled oxygen and pH conditions. Enhanced starting concentration of glycerol as a carbon source led to extended FO synthesis, supported by pH control at 7 ± 0.05. Most pronouncedly, the effect of oxygen limitation during the heterologous production of FbiC and biosynthesis of FO not only proved beneficial for FO synthesis but at the same time suppressed riboflavin synthesis. Furthermore, online fluorescence monitoring of product titers within the bioreactor showed that FO biosynthesis is linked to cell growth. The fermentation process presented here yielded a FO titer of 13.91 µmol L−1 (or 5.05 mg L−1), which, to our knowledge, is the highest reported thus far. It should be highlighted that simultaneously to the bioprocess optimization, it was very important to develop a robust purification process that delivered pure FO. In this regard, a three‐step chromatography process utilizing the effects of different pH and protonation states of the compounds was necessary to discriminate and separate FO from other flavin congeners like riboflavin. NMR analysis confirmed the high purity of the harvested FO, which is now available for further studies.
The general research focus on and applications for FO are still rather low in comparison to its phosphorylated form FOP and the full cofactor F420, with much more active research regarding their functionality and activity in biotechnologically relevant enzymatic reactions. That said, a vast range of F420‐dependent enzymes has not been characterized yet. To simplify the assessment of these enzymes—since the F420 cofactor is fairly hard to obtain—it would be convenient to enable investigations with a cofactor like FO that is now available in higher abundance and can be reproduced conveniently, without extensive strain handling. Furthermore, there is a great possibility that our findings for improved FO biosynthesis in E. coli can be advantageous for the future full biosynthesis process of F420 in E. coli itself, since FO as an F420 precursor is needed in any F420 biosynthesis process. Fraaije et al. already showed that the FO biosynthetic step can be crucial for further deazaflavin synthesis and that some species like Saccharomyces are unable to heterologously produce FO, even after extensive engineering, and external supply of the precursor is necessary for any further investigation [36, 37]. Last but not least, FO by itself is increasingly coming into the focus of research. New roles in direct biocatalysis or different functions were proposed. It was recently found to be an important factor in inter‐kingdom communication, and it can be speculated, that this finding opens up a whole new area of investigations, not as a pure redox cofactor but as a signaling molecule [38]. In conclusion, an increased availability of FO can be of great importance for further research, and further optimization of the bioproduction process is a worthwhile investment on many sides.
Author Contributions
Annika Lenić: conceptualization, methodology, investigation, formal analysis, data curation, writing – original draft preparation. Bettina Bardl: investigation, reviewing and editing. Florian Kloss: investigation, formal analysis, reviewing, and editing. Gundela Peschel: methodology, reviewing and editing. Ivan Schlembach: methodology, data curation, reviewing, and editing. Gerald Lackner: methodology, resources, reviewing and editing. Lars Regestein: conceptualization, methodology, data curation, reviewing, and editing. Miriam A. Rosenbaum: supervision, conceptualization, visualization, funding acquisition, reviewing, and editing.
Conflicts of Interest
The authors declare no conflicts of interest.
Supporting information
Supporting information
Acknowledgments
A. Lenic would like to thank Daniel Last (previously group of Synthetic Microbiology, Leibniz‐Institute for Natural Product Research and Infection Biology, Hans‐Knöll‐Institute) for the introduction into preliminary work to this study and for initial FO sample analysis. Graphical Schemes in Figures 1, 2, 3, 4, 5 were created with Biorender.com. This work was conducted with funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program eMICROBe to Miriam A. Rosenbaum (Grant agreement No. 864669). Further, Miriam A. Rosenbaum acknowledges support by the Cluster of Excellence “Balance of the Microverse” under Germany's Excellence Strategy (EX 2051–project ID 390713860) and from the Free State of Thuringia (project number 2019 FGI 0006).
Open access funding enabled and organized by Projekt DEAL.
Funding: This work was conducted with funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program eMICROBe to Miriam A. Rosenbaum (grant agreement No. 864669). Further, Miriam A. Rosenbaum acknowledges support by the Cluster of Excellence ‘Balance of the Microverse’ under Germany's Excellence Strategy (EX 2051–project ID 390713860) and from the Free State of Thuringia (project number 2019 FGI 0006).
Data Availability Statement
The data that support the findings of this study are available within this article and its supplementary materials or are available upon requesting it from the corresponding authors.
References
- 1. Braga D., Hasan M., Kröber T., Last D., and Lackner G., “Redox Coenzyme F420 Biosynthesis in Thermomicrobia Involves Reduction by Stand‐Alone Nitroreductase Superfamily Enzymes,” Applied and Environmental Microbiology 86, no. 12 (2020): e00457–20, 10.1128/AEM.00457-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Braga D., Last D., Hasan M., et al., “Metabolic Pathway Rerouting in Paraburkholderia rhizoxinica Evolved Long‐Overlooked Derivatives of Coenzyme F420,” ACS Chemical Biology 14, no. 9 (2019): 2088–2094, 10.1021/acschembio.9b00605. [DOI] [PubMed] [Google Scholar]
- 3. Lackner G., Peters E. E., Helfrich E. J. N., and Piel J., “Insights Into the Lifestyle of Uncultured Bacterial Natural Product Factories Associated With Marine Sponges,” Proceedings of the National Academy of Sciences 114, no. 3 (2017): E347–E356, 10.1073/pnas.1616234114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Ney B., Ahmed F. H., Carere C. R., et al., “The Methanogenic Redox Cofactor F 420 is Widely Synthesized by Aerobic Soil Bacteria,” ISME Journal 11, no. 1 (2017): 125–137, 10.1038/ismej.2016.100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Grinter R. and Greening C., “Cofactor F420: An Expanded View of Its Distribution, Biosynthesis and Roles in Bacteria and Archaea,” FEMS Microbiology Reviews 45, no. 5 (2021): 1–46, 10.1093/femsre/fuab021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Drenth J., Trajkovic M., and Fraaije M. W., “Chemoenzymatic Synthesis of an Unnatural Deazaflavin Cofactor that can Fuel F420‐Dependent Enzymes,” ACS Catalysis 9, no. 7 (2019): 6435–6443, 10.1021/acscatal.9b01506. [DOI] [Google Scholar]
- 7. Greening C., Jirapanjawat T., Afroze S., et al., “Mycobacterial F420H2‐Dependent Reductases Promiscuously Reduce Diverse Compounds Through a Common Mechanism,” Frontiers in Microbiology 8 (2017): 1–10, 10.3389/fmicb.2017.01000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Kang S. W., Antoney J., Lupton D. W. L., Speight R., Scott C., and Jackson C. J., “Asymmetric Ene‐Reduction by F 420‐Dependent Oxidoreductases B (FDOR‐B) From Mycobacterium smegmatis ,” Chembiochem 24 (2023): e202200797, 10.1002/cbic.202200797. [DOI] [PubMed] [Google Scholar]
- 9. Martin C., Tjallinks G., Trajkovic M., and Fraaije M. W., “Facile Stereoselective Reduction of Prochiral Ketones by Using an F 420‐Dependent Alcohol Dehydrogenase,” Chembiochem 22 (2021): 156–159, 10.1002/cbic.202000651. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Mathew S., Trajkovic M., Kumar H., Nguyen Q. T., and Fraaije M. W., “Enantio‐ and Regioselective Ene‐Reductions Using F420H2‐Dependent Enzymes,” Chemical Communications 54, no. 79 (2018): 11208–11211, 10.1039/c8cc04449j. [DOI] [PubMed] [Google Scholar]
- 11. Shah M. V., Antoney J., Kang S. W., et al., “Cofactor F420‐Dependent Enzymes: An Under‐Explored Resource for Asymmetric Redox Biocatalysis,” Catalysts 9 no. 10 (2019): 868, 10.3390/catal9100868. [DOI] [Google Scholar]
- 12. Taylor M. C., Jackson C. J., Tattersall D. B., et al., “Identification and Characterization of Two Families of F 420 H 2‐Dependent Reductases From Mycobacteria that Catalyse Aflatoxin Degradation,” Molecular Microbiology 78, no. 3 (2010): 561–575, 10.1111/j.1365-2958.2010.07356.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Taylor M., Scott C., and Grogan G., “F420‐Dependent Enzymes—Potential for Applications in Biotechnology,” Trends in Biotechnology 31, no. 2 (2013): 63–64, 10.1016/j.tibtech.2012.09.003. [DOI] [PubMed] [Google Scholar]
- 14. Greening C., Ahmed F. H., Mohamed A. E., et al., “Physiology, Biochemistry, and Applications of F 420 ‐ and Fo‐Dependent Redox Reactions,” Microbiology and Molecular Biology Reviews 80, no. 2 (2016): 451–493, 10.1128/mmbr.00070-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Bashiri G., “Cofactor F420, an Emerging Redox Power in Biosynthesis of Secondary Metabolites,” Biochemical Society Transactions 50, no. 1 (2022): 253–267, 10.1042/BST20211286. [DOI] [PubMed] [Google Scholar]
- 16. Gurumurthy M., Rao M., Mukherjee T., et al., “A Novel F 420‐Dependent Anti‐Oxidant Mechanism Protects Mycobacterium tuberculosis Against Oxidative Stress and Bactericidal Agents,” Molecular Microbiology 87, no. 4 (2013): 744–755, 10.1111/mmi.12127. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Hartzell P. L., Zvilius G., Escalante‐Semerena J. C., and Donnelly M. I., “Coenzyme F420 Dependence of the Methylenetetrahydromethanopterin Dehydrogenase of Methanobacteriumthermoautotrophicum,” Biochemical and Biophysilogical Research Communications 133, no. 3 (1985): 884–890, 10.1016/0006-291X(85)91218-5. [DOI] [PubMed] [Google Scholar]
- 18. Tzeng S. F., Wolfe R. S., and Bryant M. P., “Factor 420‐Dependent Pyridine Nucleotide‐Linked Hydrogenase System of Methanobacterium ruminantium ,” Journal of Bacteriology 121, no. 1 (1975): 154–191, 10.1128/jb.121.1.184-191.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Bashiri G., Antoney J., Jirgis E. N. M., et al., “A Revised Biosynthetic Pathway for the Cofactor F 420 in Prokaryotes,” Nature Communications 10, no. 1 (2019): 1558, 10.1038/s41467-019-09534-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Isabelle D., Simpson D. R., and Daniels L., “Large‐Scale Production of Coenzyme F420‐5,6 by Using Mycobacterium smegmatis ,” Applied and Environmental Microbiology 68, no. 11 (2002): 5750–5755, 10.1128/AEM.68.11.5750-5755.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Bashiri G., Rehan A. M., Greenwood D. R., Dickson J. M. J., and Baker E. N., “Metabolic Engineering of Cofactor F420 Production in Mycobacterium smegmatis ,” PLoS ONE 5, no. 12 (2010), 10.1371/journal.pone.0015803. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Grinter R., Neyr B., Brammananth R., et al., “Cellular and Structural Basis of Synthesis of the Unique Intermediate Dehydro‐F 420 ‐0 in Mycobacteria,” MSystems 5, no. 3 (2020): e00389‐20, 10.1128/mSystems.00389-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Last D., Hasan M., Rothenburger L., Braga D., and Lackner G., “High‐Yield Production of Coenzyme F420 in Escherichia coli by Fluorescence‐Based Screening of Multi‐Dimensional Gene Expression Space,” Metabolic Engineering 73 (2022): 158–167, 10.1016/j.ymben.2022.07.006. [DOI] [PubMed] [Google Scholar]
- 24. Shah M. V., Nazem‐Bokaee H., Antoney J., Kang S. W., Jackson C. J., and Scott C., “Improved Production of the Non‐Native Cofactor F420 in Escherichia coli ,” Scientific Reports 11, no. 1 (2021): 21774, 10.1038/s41598-021-01224-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Kern R., Keller P. J., Schmidt G., and Bacher A., “Isolation and Structural Identification of a Chromophoric Coenzyme F420 Fragment From Culture Fluid of Methanobacterium thermoautotrophicum ,” Archives of Microbiology 136 (1983): 191–193, 10.1007/BF00409842. [DOI] [Google Scholar]
- 26. Peck M. W., “Changes in Concentrations of Coenzyme F420 Analogs During Batch Growth of Methanosarcina barkeri and Methanosarcina mazei ,” Applied and Environmental Microbiology 55, no. 4 (1989): 940–945, 10.1128/aem.55.4.940-945.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Eker A. P. M., Dekker R. H., and Berends W., “Photoreactivating Enzyme From Streptomyces griseus —IV. On the Nature of the Chromophoric Cofactor in Streptomyces griseus Photoreactivating Enzyme,” Photochemistry and Photobiology 33 (1981): 65–77, 10.1111/j.1751-1097.1981.tb04298.x. [DOI] [PubMed] [Google Scholar]
- 28. Sancar A., “Structure and Function of DNA Photolyase and Cryptochrome Blue‐Light Photoreceptors,” Chemical Reviews 103, no. 6 (2003): 2203–2237, 10.1021/bi00167a001. [DOI] [PubMed] [Google Scholar]
- 29. Hossain M. S., Le C. Q., Joseph E., Nguyen T. Q., Johnson‐Winters K., and Foss F. W., “Convenient Synthesis of Deazaflavin Cofactor FO and Its Activity in F420‐Dependent NADP Reductase,” Organic and Biomolecular Chemistry 13, no. 18 (2015): 5082–5085, 10.1039/c5ob00365b. [DOI] [PubMed] [Google Scholar]
- 30. Jacobson F. S., Daniels L., Fox J. A., Walsh C. T., and Orme‐Johnson W. H., “Purification and Properties of an 8‐Hydroxy‐5‐Deazaflavin‐Reducing Hydrogenase From Methanobacterium thermoautotrophicum ,” Journal of Biological Chemistry 257, no. 7 (1982): 3385–3388, 10.1016/s0021-9258(18)34788-4. [DOI] [PubMed] [Google Scholar]
- 31. Warkentin E., Mamat B., Sordel‐Klippert M., et al., “Structures of F420H2: NADP+ Oxidoreductase With and Without its Substrates Bound,” EMBO Journal 20, no. 23 (2001): 6561–6569, 10.1093/emboj/20.23.6561. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Cellitti S. E., Shaffer J., Jones D. H., et al., “Structure of Ddn, the Deazaflavin‐Dependent Nitroreductase From Mycobacterium Tuberculosis Involved in Bioreductive Activation of PA‐824,” Structure 20, no. 1 (2012): 101–112, 10.1016/j.str.2011.11.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Kang S. W., Antoney J., Frkic R. L., et al., “Asymmetric Ene‐Reduction of α,β‐Unsaturated Compounds by F420‐Dependent Oxidoreductases A Enzymes From Mycobacterium smegmatis,” Biochemistry 62, no. 3 (2023): 873–891, 10.1021/acs.biochem.2c00557. [DOI] [PubMed] [Google Scholar]
- 34. Susanti D., Loganathan U., and Mukhopadhyay B., “A Novel F420‐Dependent Thioredoxin Reductase Gated by Low Potential FAD,” Journal of Biological Chemistry 291, no. 44 (2016): 23084–23100, 10.1074/jbc.M116.750208. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Yang G., Wijma H. J., Rozeboom H. J., Mascotti M. L., and Fraaije M. W., “Identification and Characterization of Archaeal and Bacterial F 420‐Dependent Thioredoxin Reductases,” FEBS Journal 290, no. 19 (2023): 4777–4791, 10.1111/febs.16896. [DOI] [PubMed] [Google Scholar]
- 36. Lee M., Drenth J., Trajkovic M., de Jong R. M., and Fraaije M. W., “Introducing an Artificial Deazaflavin Cofactor in Escherichia coli and Saccharomyces cerevisiae ,” ACS Synthetic Biology 11, no. 2 (2022): 938–952, 10.1021/acssynbio.1c00552. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Lee M. and Fraaije M. W., “Equipping Saccharomyces cerevisiae With an Additional Redox Cofactor Allows F420‐Dependent Bioconversions in Yeast,” ACS Synthetic Biology 13, no. 3 (2024): 921–929, 10.1021/acssynbio.3c00718. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Richter I., Hasan M., Kramer J. W., et al., “Deazaflavin Metabolite Produced by Endosymbiotic Bacteria Controls Fungal Host Reproduction,” ISME Journal 18 (2024): wrae074, 10.1093/ismejo/wrae074. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Graham D. E., Xu H., and White R. H., “Identification of the 7,8‐Didemethyl‐8‐Hydroxy‐5‐Deazariboflavin Synthase Required for Coenzyme F420 Biosynthesis,” Archives of Microbiology 180, no. 6 (2003): 455–464, 10.1007/s00203-003-0614-8. [DOI] [PubMed] [Google Scholar]
- 40. Choi K. P., Kendrick N., and Daniels L., “Demonstration that fbiC is Required by Mycobacterium bovis BCG for Coenzyme F420 and FO Biosynthesis,” Journal of Bacteriology 184, no. 9 (2002): 2420–2428, 10.1128/JB.184.9.2420-2428.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Philmus B., Decamps L., Berteau O., and Begley T. P., “Biosynthetic Versatility and Coordinated Action of 5′‐Deoxyadenosyl Radicals in Deazaflavin Biosynthesis,” Journal of the American Chemical Society 137, no. 16 (2015): 5406–5413, 10.1021/ja513287k. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Decamps L., Philmus B., Benjdia A., White R., Begley T. P., and Berteau O., “Biosynthesis of F0, Precursor of the F420 Cofactor, Requires a Unique Two Radical‐SAM Domain Enzyme and Tyrosine as Substrate,” Journal of the American Chemical Society 134, no. 44 (2012): 18173–18176, 10.1021/ja307762b. [DOI] [PubMed] [Google Scholar]
- 43. Abbas C. A. and Sibirny A. A., “Genetic Control of Biosynthesis and Transport of Riboflavin and Flavin Nucleotides and Construction of Robust Biotechnological Producers,” Microbiology and Molecular Biology Reviews 75, no. 2 (2011): 321–360, 10.1128/mmbr.00030-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Bacher A., Eberhardt S., Eisenreich W., et al., “Biosynthesis of Riboflavin,” Vitamins and Hormones 61 (2001): 1–49, 10.1016/S0083-6729(01)61001-X. [DOI] [PubMed] [Google Scholar]
- 45. Blunt W., Dartiailh C., Sparling R., Gapes D., Levin D. B., and Cicek N., “Microaerophilic Environments Improve the Productivity of Medium Chain Length Polyhydroxyalkanoate Biosynthesis From Fatty Acids in Pseudomonas putida LS46,” Process Biochemistry 59 (2017): 18–25, 10.1016/j.procbio.2017.04.028. [DOI] [Google Scholar]
- 46. García A., Castillo T., Ramos D., et al., “Molecular Weight and Viscosifying Power of Alginates Produced by Mutant Strains of Azotobacter vinelandii Under Microaerophilic Conditions,” Biotechnology Reports 26 (2020): e00436, 10.1016/j.btre.2020.e00436. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. Gómez‐Hernández E., Salgado‐Lugo H., Segura D., García A., Díaz‐Barrera A., and Peña C., “Production of Poly‐3‐Hydroxybutyrate (P3HB) With Ultra‐High Molecular Weight (UHMW) by Mutant Strains of Azotobacter vinelandii Under Microaerophilic Conditions,” Applied Biochemistry and Biotechnology 193, no. 1 (2021): 79–95, 10.1007/s12010-020-03384-w. [DOI] [PubMed] [Google Scholar]
- 48. Heyman B., Lamm R., Tulke H., Regestein L., and Büchs J., “Shake Flask Methodology for Assessing the Influence of the Maximum Oxygen Transfer Capacity on 2,3‐Butanediol Production,” Microbial Cell Factories 18, no. 1 (2019): 1–16, 10.1186/s12934-019-1126-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Clark G. J., Langley D., and Bushelll M. E., “Oxygen Limitation Can Induce Microbial Secondary Metabolite Formation: Investigations With Miniature Electrodes in Shaker and Bioreactor Culture,” Microbiology 141 (1995): 663–669, 10.1099/13500872-141-3-663. [DOI] [Google Scholar]
- 50. Peña‐Ortiz L., Schlembach I., Lackner G., and Regestein L., “Impact of Oxygen Supply and Scale Up on Mycobacterium smegmatis Cultivation and Mycofactocin Formation,” Frontiers in Bioengineering and Biotechnology 8 (2020): 1–13, 10.3389/fbioe.2020.593781. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51. Hu J., Lei P., Mohsin A., et al., “Mixomics Analysis of Bacillus subtilis: Effect of Oxygen Availability on Riboflavin Production,” Microbial Cell Factories 16, no. 1 (2017): 1–16, 10.1186/s12934-017-0764-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52. You J., Yang C., Pan X., et al., “Metabolic Engineering of Bacillus subtilis for Enhancing Riboflavin Production by Alleviating Dissolved Oxygen Limitation,” Bioresource Technology 333 (2021): 125228, 10.1016/j.biortech.2021.125228. [DOI] [PubMed] [Google Scholar]
- 53. Kufs J. E., Hoefgen S., Rautschek J., et al., “Rational Design of Flavonoid Production Routes Using Combinatorial and Precursor‐Directed Biosynthesis,” ACS Synthetic Biology 9, no. 7 (2020): 1823–1832, 10.1021/acssynbio.0c00172. [DOI] [PubMed] [Google Scholar]
- 54. Anderlei T., Zang W., Papaspyrou M., and Büchs J., “Online Respiration Activity Measurement (OTR, CTR, RQ) in Shake Flasks,” Biochemical Engineering Journal 17, no. 3 (2004): 187–194, 10.1016/S1369-703X(03)00181-5. [DOI] [Google Scholar]
- 55. Möckel H.‐O., Weißgärber H., and Börner K., “Der Leistungseintrag in belüfteten Rührsystemen mit niedrigviskosen Medien,” Chemische Technik 35, no. 7 (1983): 344–347. [Google Scholar]
- 56. Andrews W. H. and Presnell M. W., “Rapid Recovery of Escherichia coli From Estuarine Water,” Applied Microbiology 23, no. 3 (1972): 521–523, 10.1128/aem.23.3.521-523.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57. Eirich L. D., Vogels G. D., and Wolfe R. S., “Proposed Structure for Coenzyme F420 From Methanobacterium,” Biochemistry 17, no. 22 (1978): 4583–4593, 10.1021/bi00615a002. [DOI] [PubMed] [Google Scholar]
- 58. Hemmerich P., Massey V., and Fenner H., “Flavin and 5‐Deazaflavin: A Chemical Evaluation of ‘Modified’ Flavoproteins With Respect to the Mechanisms of Redox Biocatalysis,” FEBS Letters 84, no. 1 (1977): 5–21, 10.1016/0014-5793(77)81047-8. [DOI] [PubMed] [Google Scholar]
- 59. Jacobson F. and Walsh C., “Properties of 7, 8‐Didemethyl‐8‐Hydroxy‐5‐Deazaflavins Relevant to Redox Coenzyme Function in Methanogen Metabolism,” Biochemistry 23, no. 5 (1984): 979–988, 10.1021/bi00300a028. [DOI] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Supporting information
Data Availability Statement
The data that support the findings of this study are available within this article and its supplementary materials or are available upon requesting it from the corresponding authors.
